Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
9,850,113
-
Share change
-
+9,849,428
-
Total reported value
-
$157,559,817
-
Price per share
-
$16.32
-
Number of holders
-
37
-
Value change
-
+$157,548,817
-
Number of buys
-
36
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2014
As of 31 Dec 2014 Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) had 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,850,113 shares of stock of the company.
Largest 10 holders included Kohlberg Kravis Roberts & Co. L.P., RA CAPITAL MANAGEMENT, LLC, FMR LLC, VHCP Management, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, BROWN ADVISORY INC, and Cormorant Asset Management, LLC.
This table shows 37 institutional shareholders of the security as of 31 Dec 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.